Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04505540 · ClinicalTrials.gov registry record · NA
Start Treatment and Recovery for Opioid Use Disorder
A NA study, sponsored by University of Vermont.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
NCT04505540 is a NA study that has completed, run by University of Vermont. The registered enrollment target is 104 participants.
The verdict
NCT04505540, a NA study, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
Study Summary
The purpose of this study is 1) to evaluate whether emergency department-initiated medically assisted treatment with Buprenorphine/Naloxone in patients presenting with opioid use disorder will produce positive outcomes at 1 week, 3 months and 6 months after treatment initiation.
Interventions
- OTHER Bridge Clinic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2019-09-30 |
| Est. Completion | 2022-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04505540
The ClinicalTrials.gov registry entry for NCT04505540 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bridge Clinic is the first listed.
NCT04505540 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04505540 about?
NCT04505540 is a clinical study titled "Start Treatment and Recovery for Opioid Use Disorder". The purpose of this study is 1) to evaluate whether emergency department-initiated medically assisted treatment with Buprenorphine/Naloxone in patients presenting with opioid use disorder will produce positive outcomes at 1 week, 3 months and 6 months after treatment initiation.
What is the current status of trial NCT04505540?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2019-09-30. Estimated completion is 2022-10-31.
What interventions are being tested in trial NCT04505540?
The interventions under investigation include: Bridge Clinic (OTHER).
Who is sponsoring clinical trial NCT04505540?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.